Skip to content
X
![]()
X
Kodiak Announces Positive Topline Phase 3 Results
Zenkuda™ (tarcocimab tedromer) Demonstrated Superiority Over Sham in GLOW2, the Second Phase 3 Study in Diabetic Retinopathy
×
FORWARD LOOKING STATEMENTS
This site contains forward-looking statements and information. The use of words such as “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “project,” “intend,” “future,” “potential,” or “continue,” and other similar expressions are intended to identify forward-looking statements. Any forward-looking statement speaks only as of the date on which it was made. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. Actual results could differ materially from those projected in such forward-looking statements.